138 related articles for article (PubMed ID: 32819238)
1. A Study of Metabolic Parameters in Patients with Gout: A Single Center Study from Nepal.
Vaidya B; Baral R; Lama LD; Joshi R; Bhochhibhoya M; Nakarmi S
Endocr Metab Immune Disord Drug Targets; 2021; 21(6):1090-1095. PubMed ID: 32819238
[TBL] [Abstract][Full Text] [Related]
2. Gender difference in the association between gout at diagnosis and metabolic syndrome in African population: a retrospective cohort study.
Lekpa FK; Bebey FS; Bouallo I; Njonnou SRS; Luma HN; Singwe-Ngandeu M; Choukem SP
Pan Afr Med J; 2022; 43():164. PubMed ID: 36825121
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal.
Pardhe BD; Shakya S; Bhetwal A; Mathias J; Khanal PR; Pandit R; Shakya J; Joshi HO; Marahatta SB
BMC Gastroenterol; 2018 Jul; 18(1):109. PubMed ID: 29980170
[TBL] [Abstract][Full Text] [Related]
4. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome: prevalence and risk factors in Korean gout patients.
Jung JH; Song GG; Ji JD; Lee YH; Kim JH; Seo YH; Choi SJ
Korean J Intern Med; 2018 Jul; 33(4):815-822. PubMed ID: 27729624
[TBL] [Abstract][Full Text] [Related]
6. Visceral fat obesity is highly associated with primary gout in a metabolically obese but normal weighted population: a case control study.
Lee J; Lee JY; Lee JH; Jung SM; Suh YS; Koh JH; Kwok SK; Ju JH; Park KS; Park SH
Arthritis Res Ther; 2015 Mar; 17(1):79. PubMed ID: 25889813
[TBL] [Abstract][Full Text] [Related]
7. A Clinical Profile of Patients with Hyperuricemia and the Relationship between Hyperuricemia and Metabolic Syndrome: A Cross-sectional Study at a Tertiary Hospital in the Indian Population.
Rajadhyaksha A; Sarate N; Raghorte N; Ingawale S
J Assoc Physicians India; 2022 May; 70(5):11-12. PubMed ID: 35598135
[TBL] [Abstract][Full Text] [Related]
8. Association of Obesity based on Different Metabolic Status with Risk of Gout Occurrence in Patients: A National Study.
Wang Y; Liu L; Ma S; Han J; Wang Z; Fan X; Hou X
Endocr Metab Immune Disord Drug Targets; 2024; 24(8):973-980. PubMed ID: 37702179
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and characteristics of metabolic syndrome in gout patients in a hospital setting in sub-Saharan Africa.
Doualla-Bija M; Lobe Batchama Y; Moutchia-Suh J; Ama Moor VJ; Kamdem F; Lekpa FK; Luma Namme H
Diabetes Metab Syndr; 2018 Nov; 12(6):1007-1011. PubMed ID: 29980454
[TBL] [Abstract][Full Text] [Related]
10. Patients With Early-Onset Gout and Development of Earlier Severe Joint Involvement and Metabolic Comorbid Conditions: Results From a Cross-Sectional Epidemiologic Survey.
Pascart T; Norberciak L; Ea HK; Guggenbuhl P; Lioté F
Arthritis Care Res (Hoboken); 2019 Jul; 71(7):986-992. PubMed ID: 30022604
[TBL] [Abstract][Full Text] [Related]
11. GOSPEL: prospective survey of gout in France. Part I: design and patient characteristics (n = 1003).
Lioté F; Lancrenon S; Lanz S; Guggenbuhl P; Lambert C; Saraux A; Chiarelli P; Delva C; Aubert JP; Ea HK
Joint Bone Spine; 2012 Oct; 79(5):464-70. PubMed ID: 22281230
[TBL] [Abstract][Full Text] [Related]
12. Gout and Metabolic Syndrome: a Tangled Web.
Thottam GE; Krasnokutsky S; Pillinger MH
Curr Rheumatol Rep; 2017 Aug; 19(10):60. PubMed ID: 28844079
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of lipid peroxidation and antioxidants' status in metabolic syndrome.
Shrestha S; Chandra L; Aryal M; Das BK; Pandey S; Baral N
Kathmandu Univ Med J (KUMJ); 2010; 8(32):382-6. PubMed ID: 22610766
[TBL] [Abstract][Full Text] [Related]
14. Performance of the 2015 American College of Rheumatology/European League Against Rheumatism gout classification criteria in Thai patients.
Louthrenoo W; Jatuworapruk K; Lhakum P; Pattamapaspong N
Rheumatol Int; 2017 May; 37(5):705-711. PubMed ID: 28349197
[TBL] [Abstract][Full Text] [Related]
15. Association of uric acid levels with components of metabolic syndrome and non-alcoholic fatty liver disease in overweight or obese children and adolescents.
Cardoso AS; Gonzaga NC; Medeiros CC; Carvalho DF
J Pediatr (Rio J); 2013; 89(4):412-8. PubMed ID: 23791233
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and Risk Factors for Metabolic Syndrome among Hypertensive Patients Attending the General Outpatient Clinic of a Tertiary Hospital in North Central Nigeria.
Ezeala AC; Yohanna S; Obilom RE
West Afr J Med; 2019; 36(1):5-10. PubMed ID: 30924110
[TBL] [Abstract][Full Text] [Related]
17. Blood pressure control and components of the metabolic syndrome: the GOOD survey.
Zidek W; Naditch-Brûlé L; Perlini S; Farsang C; Kjeldsen SE
Cardiovasc Diabetol; 2009 Sep; 8():51. PubMed ID: 19754934
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China.
Nan H; Qiao Q; Dong Y; Gao W; Tang B; Qian R; Tuomilehto J
J Rheumatol; 2006 Jul; 33(7):1346-50. PubMed ID: 16821269
[TBL] [Abstract][Full Text] [Related]
19. Metabolic health and its association with lifestyle habits according to nutritional status in Chile: A cross-sectional study from the National Health Survey 2016-2017.
Fernández-Verdejo R; Moya-Osorio JL; Fuentes-López E; Galgani JE
PLoS One; 2020; 15(7):e0236451. PubMed ID: 32697789
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of gout patients according to the laterality of nephrolithiasis: A cross-sectional study using helical computed tomography.
Shimizu T; Hori H; Umeyama M; Shimizu K
Int J Rheum Dis; 2019 Apr; 22(4):567-573. PubMed ID: 30485677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
